Please update your browser.
Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for over 35 years.
At Genentech, we use human genetic information to discover, develop, manufacture and commercialize medicines to treat patients with serious or life-threatening medical conditions. Today, we are among the world's leading biotech companies, with multiple products on the market and a promising development pipeline.
You're Now Leaving This Site
JPMorgan Chase is not responsible for, and does not provide or endorse, this third-party site's products, services or other content. Our privacy and security practices do not apply to the site you're about to enter, so please review the third party's privacy and security practices.